INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2013

Intangible assets are comprised of patents acquired in October, 2005. Intangible assets, net consisted of the following at March 31, 2013 and December 31, 2012:

Intangible assets	March 31, 2013			December 31, 2012
Patent - Amlexanox (Aphthasol®)	$	2,090,000		$	2,090,000
Patent - Amlexanox (OraDisc™ A)		6,873,080			6,873,080
Patent - OraDisc™		73,000			73,000
Patent - Hydrogel nanoparticle aggregate		589,858			589,858
		9,625,938			9,625,938
Less: accumulated amortization		( 5,597,114	)		(5,479,953	)
Intangible assets, net	$	4,028,824		$	4,145,985

Future aggregate amortization expense for intangible assets

The future aggregate amortization expense for intangible assets, remaining as of March 31, 2013, is as follows:

Calendar Years	Future Amortization Expense
2013 (Nine months)	$	357,987
2014		475,148
2015		475,148
2016		476,450
2017		475,148
2018 & Beyond		1,768,943
Total	$	4,028,824